Renal Cancer Research Fund Scotland
The two main objectives of the Renal Cancer Research Fund Scotland (RCRF) are to raise awareness of kidney cancer and help advance kidney cancer treatment. We do this by inviting speakers (who are involved in kidney cancer research) to some of our events, and we talk ourselves to various local organisations. We have various fundraising events throughout the year such as our annual Green Ribbon Ball, fun run, Mad Hatters tea party, Prestwick Proms, Coffee mornings, fashion shows, and Christmas Fayre. To date we’ve raised in the region of £100,000, and with those funds we’ve:
- Helped buy a cryotherapy machine for the Beatson/Gartnavel Hospital in Glasgow, which is used to treat kidney cancer patients with smaller tumours less invasively (it can treat other cancers too, such as prostate).
- Sponsored a renal cancer specialist research assistant and the work she was doing based at Glasgow University. This research team (headed up by Professor Joanne Edwards) were investigating the role of Src kinase and Src kinase family members in the development and progression of renal cancer. They have demonstrated that members of this protein pathway are associated with renal cancer patients having a poor outcome. Therefore they have investigated the impact of inhibiting this protein pathway.
- Helped fund ongoing research by the Edinburgh Urology Cancer Group (which was headed up by Grant Stewart) based at Edinburgh University, who are stratifying patients with metastatic kidney cancer so they can be treated with the correct drug (personalised medicine). They are also looking at the complexity of kidney cancer to identify a possible biomarker. Another area of important research this group are investigating is the development of biomarkers to improve the ability to tell which patients who have had their kidney removed for cancer will develop a recurrence of the disease (a prognostic biomarker).
- Helped fund the startup of a new website for kidney cancer patients and their carers. This project is patient-led by members of the Kidney Cancer Support Network (KCSN) and will provide patients with information about drug funding, drugs available, research and a clinical trials database.